Truist Financial Corp Pacira Bio Sciences, Inc. Transaction History

Truist Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	BUY	$25.5 - $31.51 $377,349 - $466,284	14,798 New	14,798 $423,000
Q4 2020 Feb 18, 2021	BUY	$50.47 - $66.26 $1.13 Million - $1.48 Million	22,325 Added 63.42%	57,529 $3.44 Million
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $1.83 Million - $2.22 Million	35,204 New	35,204 $2.12 Million

261

48.9M

118K

63.7K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.